A female mummy showing anatomical signs of atherosclerotic cardiovascular disease was found to carry risky versions of seven heart disease-related SNPs.
UK and Swedish researchers used a Mendelian randomization approach to study the association between serum calcium and heart disease and heart attack risk.
The Estonian Genome Center aims to introduce genomic medicine via the country's online medical data infrastructure, according to Andres Metspalu, its director.
With exome sequencing data on nearly 10,000 individuals with or without early-onset myocardial infarction, researchers narrowed in on two genes prone to rare mutations in those at enhanced heart attack risk.
A retrospective study of patients seen over two years at the emergency department of Sweden's Karolinska University Hospital has demonstrated that using a very low cutoff point when measuring the protein biomarker cardiac troponin T could accurately rule out heart attack in a lar
NEW YORK (GenomeWeb Daily News) – A certain polymorphism in the stress-linked serotonin 2C receptor gene is linked to an increased risk of cardiovascular disease morbidity and mortality, researchers led by Duke University's Redford Williams
Clinical researchers at Beth Israel Deaconess Medical Center and Harvard Medical School have teamed up with RainDance Technologies to explore the use of RainDance's picodroplet-based digital PCR platform to measure microRNA biomarkers in the blood of patients undergoing various c
On a conference call last month following the release of its Q1 earnings, Vermillion CEO Thomas McLain announced that the company would be taking over from Quest Diagnostics as leader of commercialization efforts for its OVA1 ovarian cancer diagnostic (
NEW YORK (GenomeWeb News) – Aviir today announced the completion of a $10 million tranche, completing a financing round started in December 2011 that raised a total of $30 million.
In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.
The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.
